Of the 64 RCC patients in the discovery cohort, samples from 63 patients yielded informative staining of which 47 (75%) were positive for tumor cell‐NRP1, 45 (72%) for perivascular NRP1 and 22 (35%) for endothelial cell expressed NRP1. This evidence concerns the gene NRP1 and neoplasm.